Pictet Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.3M Sell
415,983
-20,080
-5% -$3.47M 0.07% 259
2025
Q4
$79.6M Buy
436,063
+73,925
+20% +$10.3M 0.08% 249
2025
Q3
$44M Sell
362,138
-49,712
-12% -$5.6M 0.04% 349
2025
Q2
$43M Buy
411,850
+78,645
+24% +$8.33M 0.04% 344
2025
Q1
$38.9M Buy
333,205
+328,527
+7,023% +$37.4M 0.04% 355
2024
Q4
$396K Buy
4,678
+761
+19% +$70K ﹤0.01% 1490
2024
Q3
$352K Sell
3,917
-375
-9% -$32.7K ﹤0.01% 1514
2024
Q2
$346K Sell
4,292
-348,074
-99% -$25.8M ﹤0.01% 1450
2024
Q1
$28.1M Sell
352,366
-346,566
-50% -$29.1M 0.03% 413
2023
Q4
$55.6M Buy
698,932
+52,503
+8% +$3.51M 0.06% 285
2023
Q3
$45.2M Buy
+646,429
New +$48.3M 0.06% 305

Other funds holding AXSM